Araceli Biosciences Inc.
Therapeutic discovery platform using advanced screening and characterization technologies
- Sector
- Biotech
- Headquarters
- TIGARD, OR
- Founded
- 2022
- Latest Form D
- $2.5M, Jan 2025
- Total capital
- $4.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.8M
- 2 Form D · last Jan 2025
- 21 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 20
- 20 pending · first 2023
- Rank in peer group#13 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$2.5M
- Private capital raisedForm D · SEC · 1st filing$2.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#13 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bruce William RhineDirectorNamed in SEC Form D filings
- Jeff William HarrisExecutive OfficerNamed in SEC Form D filings
- J. William FreytagDirectorNamed in SEC Form D filings
- J. William FreytagDirectorNamed in SEC Form D filings
- Kevin William GabeleinDirectorNamed in SEC Form D filings
- Kirk MalloyDirectorNamed in SEC Form D filings
Show all 12 people
- Matt BeaudetExecutive Officer, DirectorNamed in SEC Form D filings
- Samraat RahaDirectorNamed in SEC Form D filings
- Scott William IglExecutive OfficerNamed in SEC Form D filings
- Sean William O'NeillDirectorNamed in SEC Form D filings
- Shawn MacDonaldExecutive OfficerNamed in SEC Form D filings
- William B CortelyouDirectorNamed in SEC Form D filings
What it has protected
USPTO · 20 granted of 40- New patentSystems And Methods For Maximum Contrast ProjectionUSPTOUS 12,749,151
- GrantedSystems And Methods For Increasing Three-dimensional Image Quality Using Morphology-based RecompositionUSPTOUS 12,744,117
- GrantedAutomatic Image Quality And Feature Classification MethodUSPTOUS 12,676,014
Show all 40 patent records
- Systems And Methods For Maximum Contrast ProjectionSep 29, 2026 · US 12,749,151Granted
- Systems And Methods For Increasing Three-dimensional Image Quality Using Morphology-based RecompositionSep 22, 2026 · US 12,744,117Granted
- Automatic Image Quality And Feature Classification MethodJul 7, 2026 · US 12,676,014Granted
- Method And Systems For Adaptive Pixel CorrectionJul 7, 2026 · US 12,677,072Granted
- Microplate Holder For Imaging SystemJul 7, 2026 · US 12,673,325Granted
- Systems And Methods For Effect Size Optimization Of Object ClassificationMar 12, 2026 · Application 19391956Pending
- System And Method For Microscope Optical AlignmentFeb 3, 2026 · US 12,541,085Granted
- Systems And Methods For Fluorescence Microscopy Channel Crosstalk MitigationDec 30, 2025 · US 12,510,480Granted
- Systems And Methods For Increasing Three-dimensional Image Quality Using Morphology-based RecompositionDec 18, 2025 · Application 18742952Pending
- Systems And Methods For Effect Size Optimization Of Object ClassificationDec 16, 2025 · US 12,499,699Granted
- Systems And Methods For Fluorescence Microscopy Channel Crosstalk MitigationDec 2, 2025 · US 12,487,441Granted
- High Throughput Microscope AssemblyDec 2, 2025 · US 12,487,437Granted
- Method And Systems For On-demand Image Intensity CorrectionAug 19, 2025 · US 12,395,756Granted
- Compact Microscope Auto-focus AssemblyJun 24, 2025 · US 12,339,433Granted
- Methods And Systems For An Adaptive Illumination System For Imaging ApplicationsJun 24, 2025 · US 12,339,432Granted
- Method And Systems For AutofocusingMay 27, 2025 · US 12,313,835Granted
- System And Methods For Increasing Image Quality Using A Morphological-based CompositionMar 27, 2025 · Application 18472082Pending
- Photostable Crystalline Substrates For Fluorescence MicroscopyDec 19, 2024 · Application 18335770Pending
- Microplate Holder For Imaging SystemDec 3, 2024 · US 12,157,125Granted
- Systems And Methods For Maximum Contrast ProjectionNov 14, 2024 · Application 18314697Pending
- System And Method For Microscope High-speed Auto-focusing Including An Imaged Subject Based On Corrected Contrast DistributionNov 5, 2024 · US 12,135,413Granted
- High Throughput Quantitative Microscopy SystemSep 10, 2024 · US 12,085,702Granted
- Light Synchronization For An Imaging SystemJun 4, 2024 · US 12,001,001Granted
- System And Method For Microscope High-speed Auto-focusing Including An Imaged Subject Based On A Corrected Contrast DistributionAug 1, 2023 · US 11,714,273Granted
- Light Synchronization For An Imaging SystemJun 13, 2023 · US 11,675,176Granted
- Systems And Methods For Effect Size Optimization Using Cell AnnotationsApplication PCTUS2026011667Pending
- Reference Image Generation For Cell DetectionApplication PCTUS2026011686Pending
- Systems And Methods For Image RegistrationApplication PCTUS2026011665Pending
- Systems And Methods For Brightfield Cell DetectionApplication PCTUS2026011663Pending
- Reference Image Generation For Cell DetectionApplication 63775892Pending
- Systems And Methods For Effect Size Optimization Using Cell AnnotationsApplication 63746845Pending
- Systems And Methods For Brightfield Cell DetectionApplication 63746838Pending
- Systems And Methods For Image RegistrationApplication 63746842Pending
- High Throughput Microscope AssemblyApplication PCTUS2022075080Pending
- Automatic Image Qualiity And Feature Classification MethodApplication 63364708Pending
- System And Method For Microscope Optical AlignmentApplication PCTUS2024020784Pending
- Systems And Methods For Fluorescence Microscopy Channel Crosstalk MitigationApplication PCTUS2024020750Pending
- Method And Systems For On-demand Image Intensity CorrectionApplication PCTUS2024020781Pending
- Systems And Methods For Maximum Contrast ProjectionApplication PCTUS2024028634Pending
- Systems And Methods For Effect Size Optimization Of Object ClassificationApplication PCTUS2024029510Pending
Related companies, and why
- AptamiR Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Trethera CorpSimilar federal contract value in Biotech · null in contracts
- Vascugen, Inc.Similar federal contract value in Biotech · null in contracts
- Enable MedicineSimilar federal contract value in Biotech · null in contracts
- Dimension Inx Corp.Similar federal contract value in Biotech · null in contracts
- Scienture Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .